Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies

Go back to Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
Sunshine Biopharma, Inc. (NASDAQ: SBFM) Delayed: 0.17 -0.05 (22.73%)
Previous Close $0.22    52 Week High $0.04 
Open $0.17    52 Week Low $0.00 
Day High $0.19    P/E N/A 
Day Low $0.16    EPS $0.00 
Volume 3,116,739